Elevation of Cholesterol and Bile Acid Metabolism in Mice Larking Membrane Tyrosine Kinase Receptor Fgfr4

C Yu,F Wang,M Kan,C Jin,RB Jones,M Weinstein,CX Deng,WL McKeehan

DOI: https://doi.org/10.1074/jbc.275.20.15482

1999-01-01

Molecular Biology of the Cell

Abstract:Heparan sulfate-regulated transmembrane tyrosine kinase receptor FGFR4 is the major FGFR isotype in mature hepatocytes. Fibroblast growth factor has been implicated in the definition of liver from foregut endoderm where FGFR4 is expressed and stimulation of hepatocyte DNA synthesis in vitro. Here we show that livers of mice lacking FGFR4 exhibited normal morphology and regenerated normally in response to partial hepatectomy. However, the FGFR4 (−/−) mice exhibited depleted gallbladders, an elevated bile acid pool and elevated excretion of bile acids. Cholesterol- and bile acid-controlled liver cholesterol 7α-hydroxylase, the limiting enzyme for bile acid synthesis, was elevated, unresponsive to dietary cholesterol, but repressed normally by dietary cholate. Expression pattern and cholate-dependent, cholesterol-induced hepatomegaly in the FGFR4 (−/−) mice suggested that activation of receptor interacting protein 140, a co-repressor of feed-forward activator liver X receptor α, may mediate the negative regulation of cholesterol- and bile acid-controlled liver cholesterol 7α-hydroxylase transcription by FGFR4 and cholate. The results demonstrate that transmembrane sensors interface with metabolite-controlled transcription networks and suggest that pericellular matrix-controlled liver FGFR4 in particular may ensure adequate cholesterol for cell structures and signal transduction. Heparan sulfate-regulated transmembrane tyrosine kinase receptor FGFR4 is the major FGFR isotype in mature hepatocytes. Fibroblast growth factor has been implicated in the definition of liver from foregut endoderm where FGFR4 is expressed and stimulation of hepatocyte DNA synthesis in vitro. Here we show that livers of mice lacking FGFR4 exhibited normal morphology and regenerated normally in response to partial hepatectomy. However, the FGFR4 (−/−) mice exhibited depleted gallbladders, an elevated bile acid pool and elevated excretion of bile acids. Cholesterol- and bile acid-controlled liver cholesterol 7α-hydroxylase, the limiting enzyme for bile acid synthesis, was elevated, unresponsive to dietary cholesterol, but repressed normally by dietary cholate. Expression pattern and cholate-dependent, cholesterol-induced hepatomegaly in the FGFR4 (−/−) mice suggested that activation of receptor interacting protein 140, a co-repressor of feed-forward activator liver X receptor α, may mediate the negative regulation of cholesterol- and bile acid-controlled liver cholesterol 7α-hydroxylase transcription by FGFR4 and cholate. The results demonstrate that transmembrane sensors interface with metabolite-controlled transcription networks and suggest that pericellular matrix-controlled liver FGFR4 in particular may ensure adequate cholesterol for cell structures and signal transduction. fibroblast growth factor FGF receptor cholesterol 7α-hydroxylase receptor interacting protein 140 liver X receptor 3-hydroxy-3-methylglutaryl-CoA partial hepatectomy reverse transcriptase-polymerase chain reaction ileal sodium-dependent bile acid transporter intestinal bile acid-binding protein ribonuclease protection bromodeoxyuridine oxysterol 7α-hydroxylase retinoid X receptor sterol 27-hydroxylase farnesoid X receptor nucleotide(s) phosphate-buffered saline The fibroblast growth factor (FGF)1 tyrosine kinase signaling complex is an intrinsic mediator of cell to cell communication in tissue remodeling in development and cellular homeostasis in adult organs (1.Mason I.J. Cell. 1994; 78: 547-552Abstract Full Text PDF PubMed Scopus (525) Google Scholar, 2.McKeehan W.L. Wang F. Kan M. Prog. Nucleic Acids Res. Mol. Biol. 1998; 59: 135-176Crossref PubMed Scopus (361) Google Scholar). The FGF receptor kinase family consists of an extensive repertoire of alternately spliced products of four genes (fgfr1 to fgfr4), which are expressed in development in a temporal- and spatially specific mode (3.Xu X. Weinstein M. Li C. Deng C. Cell Tissue Res. 1999; 296: 33-43Crossref PubMed Scopus (127) Google Scholar) and in adult tissues in a cell type-specific mode (2.McKeehan W.L. Wang F. Kan M. Prog. Nucleic Acids Res. Mol. Biol. 1998; 59: 135-176Crossref PubMed Scopus (361) Google Scholar). Disruption of thefgfr1 and fgfr2 genes in mice disrupt development, exhibit global proliferation defects, and are embryonic lethal (4.Deng C.X. Wynshaw-Boris A. Shen M.M. Daugherty C. Ornitz D.M. Leder P. Genes Dev. 1994; 8: 3045-3057Crossref PubMed Scopus (632) Google Scholar, 5.Xu X. Weinstein M. Li C. Naski M. Cohen R.I. Ornitz D.M. Leder P. Deng C. Development. 1998; 125: 753-765Crossref PubMed Google Scholar). Mice in which fgfr3 was disrupted are viable, but exhibit severe skeletal dysplasias due to overgrowth of long bones, which is a consequence of loss of restraints on growth of chondrocytes during endochondral ossification (6.Colvin J.S. Bohne B.A. Harding G.W. McEwen D.G. Ornitz D.M. Nat. Genet. 1996; 12: 390-397Crossref PubMed Scopus (753) Google Scholar, 7.Deng C. Wynshaw-Boris A. Zhou F. Kuo A. Leder P. Cell. 1996; 84: 911-921Abstract Full Text Full Text PDF PubMed Scopus (912) Google Scholar). FGF-1, FGF-2, and FGF-8 have been implicated in definition of the liver from foregut endoderm where FGFR4 is expressed (8.Jung J. Zheng M. Goldfarb M. Zaret K.S. Science. 1999; 284: 1998-2003Crossref PubMed Scopus (607) Google Scholar). However, disruption of fgfr4 in the mouse germline resulted in no overt abnormalities (9.Weinstein M. Xu X. Ohyama K. Deng C.X. Development. 1998; 125: 3615-3623Crossref PubMed Google Scholar). All four fgfr genes are expressed in adult liver (10.Kan M. McKeehan W.L. Strain A. Diehl A. Liver Growth and Repair. 9. Chapman & Hall, London1998: 240-260Crossref Google Scholar), but only FGFR4 is expressed in mature hepatocytes (11.Kan M. Wu X. Wang F. McKeehan W.L. J. Biol. Chem. 1999; 274: 15947-15952Abstract Full Text Full Text PDF PubMed Scopus (126) Google Scholar). External administration of FGF-7 and FGF-18, or expression of FGF-18 under control of liver specific-promoters, elicits hyperplasia in the liver (12.Housley R.M. Morris C.F. Boyle W. Ring B. Biltz R. Tarpley J.E. Aukerman S.L. Devine P.L. Whitehead R.H. Pierce G.F. J. Clin. Invest. 1994; 94: 1764-1777Crossref PubMed Scopus (264) Google Scholar, 13.Hu M.C. Qiu W.R. Wang Y.P. Hill D. Ring B.D. Scully S. Bolon B. DeRose M. Luethy R. Simonet W.S. Arakawa T. Danilenko D.M. Mol. Cell. Biol. 1998; 18: 6063-6074Crossref PubMed Scopus (108) Google Scholar). FGF-1 and FGF-7 elicit DNA synthesis in primary liver cell cultures enriched in hepatocytes (14.Kan M. Huang J.S. Mansson P.E. Yasumitsu H. Carr B. McKeehan W.L. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 7432-7436Crossref PubMed Scopus (166) Google Scholar, 15.Itoh T. Suzuki M. Mitsui Y. Biochem. Biophys. Res. Commun. 1993; 192: 1011-1015Crossref PubMed Scopus (19) Google Scholar). To determine whether FGFR4 plays a role in liver in vivo, we examined the morphology of the liver and associated organs infgfr4 − /fgfr4 − mice, including the compensatory growth response after partial hepatectomy. Here we report no differences in liver architecture and kinetics or extent of restoration of liver mass between wild-type andfgfr4−/fgfr4 − animals. However, examination of liver-associated organs revealed a small, depleted gallbladder in the FGFR4-deficient mice that prompted an analysis of cholesterol and bile acid metabolism. The results revealed that the FGFR4 deficiency caused a significant elevation of the excreted and total bile acid pools. Elevation of bile acid pools were coincident with constitutively elevated expression of Cyp7a, the limiting enzyme in the classical pathway for bile acid synthesis (16.Russell D.W. Setchell K.D. Biochemistry. 1992; 31: 4737-4749Crossref PubMed Scopus (656) Google Scholar), and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, the rate-limiting step in cholesterol synthesis (17.Goldstein J.L. Brown M.S. Nature. 1990; 343: 425-430Crossref PubMed Scopus (4537) Google Scholar). The FGFR4 knockout mice exhibited a cholate-dependent, cholesterol-induced hepatomegaly. Analysis of gene expression in the hepatomegalic livers of the mutant mice suggested points where both FGFR4 and bile acids exert negative controls on liver bile acid synthesis. These results implicate the pericellular matrix-controlled FGFR4 kinase complex in hepatocytes in control of cholesterol metabolism and bile acid synthesis in a physiological setting. Disruption of the mouse fgfr4locus was carried out in 129 Sv strain-derived ES cells as described (9.Weinstein M. Xu X. Ohyama K. Deng C.X. Development. 1998; 125: 3615-3623Crossref PubMed Google Scholar). Wild-type 129 Sv mice were obtained from the Jackson Laboratory. FGFR4 (+/−) mice were generated by crossing FGFR4 (−/−) mice with wild-type 129 Sv mice, or by further crossing FGFR4 (+/−) with FGFR4 (−/−) mice. Only mice 7–8 weeks old were used in the study. Male mice were used for partial hepatectomy (PH)-induced liver regeneration experiments, and female mice were used in all other protocols. Mice were maintained in 12-h light/12-h dark cycles and were given free access to food and water. Standard rodent chow containing 0.02% (w/w) cholesterol and the standard chow supplemented with 2% (w/w) cholesterol or both 2% (w/w) cholesterol and 2% (w/w) sodium cholate was obtained from Alief Purina Feed Store, Inc. (Alief, TX). Two to four mice were employed for each experimental group, as described in the specific figure legends. After the mice were weighed, anesthetized, and exsanguinated, the livers or other tissues were harvested at 10:00 a.m., except that of the mice used in the PH-induced liver regeneration, which were harvested at the times indicated. All procedures were performed in accordance with the Institutional Animal Care and Use Committee at the Institute of Biosciences and Technology, Texas A&M University System Health Science Center. Full-length murine Cyp7a (pCMV-mCyp7a), Cyp7b (phct1), and Cyp27a (pCMV-m27OH) cDNAs were gifts from Dr. David W. Russell (University of Texas Southwestern Medical Center, Dallas, TX). Full-length murine LXRα (pCMX-mLXRα) and LXRβ (pCMX-mLXRβ) cDNAs were gifts from Dr. David J. Mangelsdorf (University of Texas Southwestern Medical Center, Dallas, TX). Murine β-actin was amplified by the reverse transcriptase polymerase chain reaction (RT-PCR) from mouse liver using sense primer 5′-GCACCAAGGTGTGATGGTG-3′ and antisense primer 5′-CGGTTGGCCTTCAGGGTTC-3′. Murine FGFR4 cDNA was amplified by RT-PCR from mouse liver using sense primer 5′-GATGGACAGGCCTTCCACGGG-3′ and antisense primer 5′-GGTTGCTGTTGTCCACGTGAGGTCTTC-3′. Murine HMG-CoA reductase cDNA was amplified by RT-PCR from mouse liver using sense primer 5′-CGAGGAAAGACTGTGGTTTG-3′ and antisense primer 5′-CACGTTCCTTGAAGATCTTG-3′. Murine RIP140 cDNA was amplified by RT-PCR from mouse liver using sense primer 5′-CAGTCCTTGTTAAACACGTG-3′ and antisense primer 5′-CGATGACAGAAGTCCTTGTG-3′. Murine ileal sodium-dependent bile acid transporter (ISBT) cDNA was amplified by RT-PCR from mouse small intestine using sense primer 5′-AGCATGACCACTTGCTCCAC-3′ and antisense primer 5′-AAAGACGAGCTGGAAAACAG-3′. Murine intestinal bile acid-binding protein (IBABP) cDNA was amplified from mouse small intestine using sense primer 5′-ACAGGACTTCACCTGGTC-3′ and antisense primer 5′-GCGCTCATAGGTCACATC-3′. All products of RT-PCR were verified by sequencing and restriction enzyme digestion. Riboprobes complementary to part of the cDNAs described above, which had been subcloned into pBluescript-SK, were transcribed into32P-labeled antisense riboprobes by T3 or T7 RNA polymerase using the MAXiscript kit (no. 1326, Ambion). The size of probes and the predicted protected fragments were as follows: β-actin, 197 and 139 nt; FGFR4, 267 and 198 nt; Cyp7a, 272 and 219 nt; Cyp7b , ∼200 and ∼170 nt; Cyp27a, 318 and 268 nt; HMG-CoA reductase, 248 and 192 nt; LXRα, 375 and 312 nt; LXRβ, ∼450 and ∼400 nt; RIP140, 306 and 228 nt; ISBT, 279 and 213 nt; and IBABP, 309 and 232 nt. Total RNA was isolated from livers or ileal tissue with the Ultraspec RNA Isolation System (BL-10200, Biotecx Laboratories) and specific mRNAs were measured by ribonuclease protection (RPA) using the HybSpeed RPA kit (no. 1412, Ambion). About 50 μg of liver or ileal RNA was hybridized with 1 × 105 cpm of 32P-labeled specific antisense and β-actin riboprobes in the same reaction mixture. After treatment with ribonuclease, protected products were analyzed on 5% polyacrylamide sequencing gels, followed by autoradiography. Size of protection products was determined from the product of a DNA sequencing reaction parallel to the protection assays. The amount of each radiographic product was quantitated using a PhosphorImager (Molecular Dynamics). The value of bands between samples was standardized by division of the value of the internal β-actin in each sample. Experimental values were expressed in units relative to the level of expression in wild-type mice on standard chow, which was assigned a value of one. Livers were homogenized in PBS containing 0.5% sodium deoxycholate and 0.1% SDS and centrifuged. The protein concentration was determined using the BCA protein assay reagent (no. 23225X, Pierce). A total of 25 μg of protein was subjected to 12% SDS-PAGE, transferred to Hybond-P membrane (Amersham Pharmacia Biotech), incubated with 1/10,000 rabbit anti-mouse CYP7A antiserum (a gift from Dr. David W. Russell), washed, and then incubated with 1/20,000 goat anti-rabbit IgG conjugated to horseradish peroxidase (Bio-Rad). Development was carried out using the Amersham ECL-Plus detection regents (Amersham Pharmacia Biotech). Bile acids were measured enzymatically using the Bile Acids kit (no. 450-A, Sigma). To determine fecal bile acid excretion, the feces from individually housed mice were collected, weighed, and dried over a 72-h period. Then 0.5 g of dried feces was minced and extracted in 10 ml of 75% ethanol at about 50 °C for 2 h. The extract was centrifuged, and 1-ml samples of supernatant were diluted for assay to 4 ml with a 25% PBS solution. The bile acid concentration was measured enzymatically. The daily feces output (g/day per 100 g of body weight) and fecal bile acid content (μmol/g) were used to calculate the rate of bile acid excretion (μmol/day/100 g of body weight). The total bile acid pool size was determined as bile acid content of the small intestine, the gallbladder, the liver, and their contents. After the mice were weighed, anesthetized, and exsanguinated, the fresh organs were collected, minced together, and extracted in 15 ml of 75% ethanol at about 50 °C for 2 h. The extract was centrifuged, 1-ml samples of supernatant for assay were diluted to 4 ml with 75% ethanol, and then 1-ml samples were diluted to 4 ml with 25% PBS. Bile acids were determined enzymatically, and the pool size was expressed as micromoles of bile acid/100 g of body weight. To measure hepatic cholesterol level, 50 mg of fresh liver was minced, hydrolyzed, and extracted in 4 ml of 1 m KOH/methanol (diluted aqueous KOH (10 m) with 9 volumes of methanol) at 66 °C for 2 h. The extract was centrifuged, and the cholesterol concentration in the supernatant was measured using a Cholesterol kit (no. 139050, Roche Molecular Biochemicals). The cholesterol level was determined and expressed as milligrams of cholesterol/g of liver weight. Liver tissues were fixed overnight in Histochoice Tissue Fixative MB (no. H120–4L, Amresco), dehydrated through a series of ethanol treatments, and embedded in paraffin according to standard procedure. Sections were prepared and stained with hematoxylin and eosin. A 70% hepatectomy, consisting of removal of the anterior and left lateral hepatic lobes, was performed on male mice at 10:00 a.m. Two hours prior to sacrifice of the animals for analysis, 50 μg/g of body weight of bromodeoxyuridine (BrdUrd) was administered intraperitoneally. Remnant livers were removed and weighed at different times. BrdUrd incorporation in fixed liver sections was visualized with an anti-BrdUrd monoclonal antibody (no. 2531, Sigma) and an alkaline phosphatase-conjugated second antibody. Positive hepatocytes were counted, and BrdUrd incorporation was expressed as the percentage of the number of labeled hepatocytes in four or five visual fields. Values are expressed as the mean ± standard deviation (S.D.) with the number of replicates described in the legends to figures. The statistical significance of differences between mean values (p < 0.05) was evaluated using the two-tailed Student's t test. A histological examination of the liver revealed no apparent abnormalities in the overall morphology, cellular content and arrangement of different compartments in wild-type (+/+) and FGFR4-deficient (−/−) mice. The knockout animals exhibited normal blood chemistry including glucose, protein, and aspartate aminotransferase and alanine aminotransferase levels (data not shown). Partial hepatectomy was performed on both FGFR4 (−/−) mice and FGFR4 (+/+) mice, and both DNA synthesis and restoration of liver mass was measured periodically for up to 168 h after the operation. DNA synthesis peaked at the expected 38-h time point, and both the rate and extent of recovery of liver mass were identical in both wild-type and mutant mice (Fig. 1, A andB). Thus, FGFR4 is either not directly involved in compensatory growth of the liver in response to loss of 67% of the liver mass, or it is fully compensated for by other proliferative regulators. During surgical manipulation of livers for partial hepatectomy, we noted that the gallbladders of FGFR4 (−/−) mice, inclusive of contents, were smaller and weighed on average about 30% of those from FGFR4 (+/+) mice (Fig.1 C). The differential was maintained in mice fed a high cholesterol/cholate diet, although gallbladders exhibited an expected 4-fold increase in total weight (Fig. 1 D). Histological analysis revealed no apparent difference in gallbladder morphology and structure between mutant and wild-type mice (data not shown). Analysis of combined liver, gallbladder, and small intestine, as well as feces from both male and female FGFR4 (−/−), FGFR4 (+/−), and FGFR4 (+/+) mice, revealed that bile acids were elevated 2–3-fold in FGFR4-deficient mice (Fig. 2,A and B). Surgical ablation of the gallbladders from wild-type and FGFR4-deficient mice had no effect on the fecal bile acid excretion rate (Fig. 2 A). This suggested that an abnormality in bile acid metabolism and flow was the cause of the smaller gallbladders in mutant mice, rather than a defect in architecture and function of the gallbladders. It has been shown previously that acceleration of bile acid synthesis, by blocking bile acid feedback inhibition by blocking intestinal uptake, can accelerate gallbladder emptying and a decrease in gallbladder volume (18.Portincasa P. Di Ciaula A. Palmieri V.O. Baldassarre G. Palasciano G. Am. J. Gastroenterol. 1994; 89: 909-914PubMed Google Scholar, 19.Portincasa P. Di Ciaula A. Palmieri V. Van Berge-Henegouwen G.P. Palasciano G. Eur. J. Clin. Invest. 1995; 25: 746-753Crossref PubMed Scopus (43) Google Scholar). Although the bile acid pool increased by an expected 60% in FGFR4 (+/+) mice on a high cholesterol diet (20.Peet D.J. Turley S.D. Ma W. Janowski B.A. Lobaccaro J.M. Hammer R.E. Mangelsdorf D.J. Cell. 1998; 93: 693-704Abstract Full Text Full Text PDF PubMed Scopus (1237) Google Scholar), the diet had little effect on the already elevated pool observed in the FGFR4-deficient animals (Fig. 2 C). Both newborn FGFR4 (+/+) and FGFR4 (−/−) animals exhibited a pool size of 20 μmol/100 g of body weight, which rose to 30 μmol/100 g on day 3 (Fig. 2 D). By day 6, the pool in FGFR4 (−/−) mice was 2 times that of normal at 60 μmol/100 g, and continued to increase through day 12, while pools were static in normal mice. During weaning, which causes an increase in the bile acid pools of both normal (21.Massimi M. Lear S.R. Huling S.L. Jones A.L. Erickson S.K. Hepatology. 1998; 28: 1064-1072Crossref PubMed Scopus (45) Google Scholar) and mutant mice, the pool in FGFR4 (−/−) mice rose to 3 times (250 μmol/100 g of body weight) that of wild-type adult levels (about 80 μmol/100 g of body weight) at 21 days. Levels in mutant mice dropped to about 160 μmol/100 g after 1 month and remained static thereafter. This indicated that an elevation of bile acid pools in the FGFR-deficient mice occurs prior to maturation of mechanisms for reabsorption of bile acids in the ileum and liver (22.von Dippe P. Levy D. J. Biol. Chem. 1990; 265: 5942-5945Abstract Full Text PDF PubMed Google Scholar, 23.Shneider B.L. Setchell K.D. Crossman M.W. Pediatr. Res. 1997; 42: 189-194Crossref PubMed Scopus (45) Google Scholar) and the secondary acid pathway for synthesis of bile acids (24.Schwarz M. Lund E.G. Lathe R. Bjorkhem I. Russell D.W. J. Biol. Chem. 1997; 272: 23995-24001Abstract Full Text Full Text PDF PubMed Scopus (143) Google Scholar). Expression of mRNA for IBABP and ISBT, whose transcription is activated and repressed by bile acids, respectively (25.Kanda T. Foucand L. Nakamura Y. Niot I. Besnard P. Fujita M. Sakai Y. Hatakeyama K. Ono T. Fujii H. Biochem. J. 1998; 330: 261-265Crossref PubMed Scopus (85) Google Scholar, 26.Torchia E.C. Cheema S.K. Agellon L.B. Biochem. Biophys. Res. Commun. 1996; 225: 128-133Crossref PubMed Scopus (52) Google Scholar), was increased and depressed, respectively, in mature FGFR4-deficient mice (Fig. 2, E and F). These observations suggested a role of FGFR4 in bile acid metabolism at the site of synthesis in the liver. Elevation of bile acids may result from accelerated conversion from cholesterol, or indirectly through increased availability of cholesterol substrate through its synthesis or deposition in the liver. Enzymes whose levels are regulated at transcription by substrates and products regulate both liver pathways (27.Rudling M. J. Lipid. Res. 1992; 33: 493-501Abstract Full Text PDF PubMed Google Scholar). We first measured mRNA levels of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis in animals on standard rodent chow (≤0.02% cholesterol w/w). HMG-CoA reductase mRNA, which is repressed by sterols and activated when they are deficient (28.Brown M.S. Goldstein J.L. J. Lipid. Res. 1980; 21: 505-517Abstract Full Text PDF PubMed Google Scholar), was elevated by 7-fold in the FGFR4 (−/−) animals, but down-regulated to near equal levels in both FGFR4 (+/+) and FGFR4 (−/−) animals fed a cholesterol-rich diet (Fig.3 A). Cyp7a, which converts cholesterol into 7α-hydroxycholesterol, is the rate-limiting enzyme in the classical route of bile acid synthesis (16.Russell D.W. Setchell K.D. Biochemistry. 1992; 31: 4737-4749Crossref PubMed Scopus (656) Google Scholar). Cyp7a is positively regulated at transcription in a feed-forward mode by oxysterol metabolites of cholesterol (29.Lehmann J.M. Kliewer S.A. Moore L.B. Smith-Oliver T.A. Oliver B.B. Su J.L. Sundseth S.S. Winegar D.A. Blanchard D.E. Spencer T.A. Willson T.M. J. Biol. Chem. 1997; 272: 3137-3140Abstract Full Text Full Text PDF PubMed Scopus (1037) Google Scholar), and negatively regulated in feedback mode by bile acids. The expression of liver Cyp7a mRNA was elevated by 2.5-fold in FGFR4 (−/−) mice compared with wild-type animals (Fig. 3 B). Immunoblot analysis revealed that the elevation of the level of CYP7A protein was similar to the rise in mRNA (Fig. 3 C). Although the high cholesterol diet increased Cyp7a expression by 1.5-fold in wild-type mice, the increase failed to reach the elevated level of Cyp7a expression observed in FGFR4 (−/−) mice (Fig. 3 B). No increase over the elevated Cyp7a mRNA levels in the FGFR4-deficient animals was observed as a consequence of the high cholesterol chow. Cholate is a strong repressor of Cyp7a transcription (30.Jelinek D.F. Andersson S. Slaughter C.A. Russell D.W. J. Biol. Chem. 1990; 265: 8190-8197Abstract Full Text PDF PubMed Google Scholar). The addition of cholate (2%, w/w) to the high cholesterol chow revealed that mechanisms for bile acid-mediated repression of Cyp7a expression were intact and similar to wild type. These combined results suggest that FGFR4 negatively regulates bile acid synthesis through repression of Cyp7a expression and that Cyp7a is constitutively elevated in its absence. FGFR4 (+/+) and FGFR4 (−/−) mice on a high cholesterol diet (Fig. 4, A andB) exhibited no significant difference in liver size or liver cholesterol concentration. When challenged with a diet containing both 2% (w/w) cholesterol and cholate that strongly repressed Cyp7a (Fig. 4 C), liver cholesterol concentration exhibited an expected increase of nearly 30 times in both wild-type and mutant mice. Unexpectedly, the liver weight in the FGFR4-deficient animals doubled within 2 weeks on the combined high cholesterol/cholate diet, and was 1.8 times larger than wild-type livers after 1 month (Figs.4 D and 5 A). Administration of cholate alone had no effect (data not shown). The cholesterol/cholate-induced hepatomegaly was confirmed by the 32% fewer hepatocytes per visual field in sections of livers from FGFR4 (−/−) mice (Fig. 5 B). A separate analysis of DNA synthesis by incorporation of BrdUrd (data not shown) confirmed that the hepatomegaly in FGFR4 (−/−) mice was due to hepatocyte hypertrophy rather than an increase in hepatocyte number.Figure 5Hepatomegaly in FGFR4 knockout mice on high cholesterol and cholate chow. A, gross morphology of livers from FGFR4 (+/+) and FGFR4 (−/−) mice fed standard chow or chow containing 2% cholesterol (Chol) and 2% cholate (Chte) for 21 days. B, histology of livers from FGFR4 (+/+) and FGFR4 (−/−) mice. Paraffin-embedded sections from livers of mice fed 2% cholesterol and 2% cholate for 21 days were sectioned and stained with hematoxylin and eosin.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Why is cholesterol-induced hepatomegaly dependent on dietary cholate, and why does it occur specifically in the FGFR4-deficient mice, which appear to be more capable of disposal of cholesterol? When Cyp7a is deficient (31.Schwarz M. Lund E.G. Setchell K.D.R. Kayden H.J. Zerwekh J.E. Bjorkhem I. Herz J. Russell D.W. J. Biol. Chem. 1996; 271: 18024-18031Abstract Full Text Full Text PDF PubMed Scopus (224) Google Scholar), the secondary acid pathway of bile acid synthesis compensates by generation and disposal of potentially hepatotoxic oxysterols from cholesterol (24.Schwarz M. Lund E.G. Lathe R. Bjorkhem I. Russell D.W. J. Biol. Chem. 1997; 272: 23995-24001Abstract Full Text Full Text PDF PubMed Scopus (143) Google Scholar, 32.Bjorkhem I. J. Lipid. Res. 1992; 33: 455-471Abstract Full Text PDF PubMed Google Scholar). Moreover, the pathway is less stringently feedback-inhibited by bile acids than the classical pathway (33.Schwarz M. Lund E.G. Russell D.W. Curr. Opin. Lipidol. 1998; 9: 113-118Crossref PubMed Scopus (86) Google Scholar). We examined expression of cholesterol 27α-hydroxylase (Cyp27a) and oxysterol 7α-hydroxylase (Cyp7b), rate-limiting enzymes of the alternative acid pathway. Nuclease protection analysis revealed no difference between expression levels of Cyp27a or Cyp7b mRNA between FGFR4 (+/+) and FGFR4 (−/−) mice on standard chow. However, Cyp27a was repressed twice as effectively in mutants as in wild-type mice on the high cholesterol/cholate combination (Fig.6 A). We also observed a decrease in Cyp27a in the mutant mice fed high cholesterol without cholate. No difference in Cyp7b expression was detected under any of the conditions (data not shown). The exaggerated depression of Cyp27a in absence of FGFR4 under conditions where Cyp7a is severely repressed may contribute to the selective hepatomegaly in the FGFR4-deficient mice. The hepatomegalic phenotype in FGFR4 (−/−) mice induced by the high cholesterol/cholate combination was similar to that induced by cholesterol alone in mice devoid of the gene for the nuclear oxysterol receptor and transcription factor LXRα (20.Peet D.J. Turley S.D. Ma W. Janowski B.A. Lobaccaro J.M. Hammer R.E. Mangelsdorf D.J. Cell. 1998; 93: 693-704Abstract Full Text Full Text PDF PubMed Scopus (1237) Google Scholar). We observed no change in the expression of LXRα or LXRβ mRNAs in all described conditions in wild-type and FGFR-deficient mice (data not shown). However, a screen for diet-dependent differences in expression of candidate co-activator/co-repressors of LXRα in the wild-type and FGFR4 knockout mice revealed that expression of the multi-functional co-activator and co-repressor RIP140 was responsive to the dietary manipulation (Fig. 6 B). Expression of RIP140 was depressed by 40% in wild-type mice fed high cholesterol, but elevated 1.8-fold in mice fed both cholesterol and cholate. RIP140 mRNA in FGFR4-deficient animals on standard chow was 30% of that in wild-type animals; the high cholesterol diet caused no further decrease, but surprisingly expression levels increased by over 10-fold in the mutant animals when cholate was added to the high cholesterol chow. RIP140 has been demonstrated to be a repressor of transcriptional activation by LXRα/retinoid X receptor (RXRα), as well as peroxisome proliferator-activated receptor α-RXRα heterodimers through interaction with LXRα or peroxisome proliferator-activated receptor α (34.Miyata K.S. McCaw S.E. Meertens L.M. Patel H.V. Rachubinski R.A. Capone J.P. Mol. Cell. Endocrinol. 1998; 146: 69-76Crossref PubMed Scopus (62) Google Scholar). Our results suggest that, in addition to direct repression of Cyp7a expression through negative bile acid response elements at transcription, bile acid products also repress Cyp7a through activation of a co-repressor (RIP140) of the oxysterol receptor an